How many shares of BMRN does Capital Research Global Investors own?

As of 2026-Q2, Capital Research Global Investors holds 3.5M shares of BMRN (BIOMARIN PHARMACEUTICAL INC).

What is Capital Research Global Investors's BMRN position worth?

As of 2026-Q2, Capital Research Global Investors's BMRN position is worth $200.5M.

Is Capital Research Global Investors buying or selling BMRN?

In 2026-Q2, Capital Research Global Investors increased their BMRN position (+0.4% change in shares).

When did Capital Research Global Investors first buy BMRN?

Based on available 13F filings, Capital Research Global Investors first reported a position in BMRN in 2018-Q4. They have held the position across 31 quarters.

Back to

Capital Research Global Investors

BMRN
31 quarters

Position history for Capital Research Global Investors's holdings in BIOMARIN PHARMACEUTICAL INC

Current Value

$200.5M

Current Shares

3.5M

Total Value Change

-$1.4B

Total Shares Change

-14.8M

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	3.5M	+0.4%	$200.5M	0.0%	$57.22	31
2026-Q1	Increased	3.5M	+37.1%	$197.2M	0.0%	$58.53	40
2025-Q4	Increased	2.5M	+0.4%	$151.4M	0.0%	$58.99	30
2025-Q3	Increased	2.5M	+547.5%	$137.4M	0.0%	$54.02	49
2025-Q2	Decreased	391,879	-95.7%	$21.5M	0.0%	$55.17	0
2025-Q1	Decreased	9.2M	-29.6%	$646.9M	0.1%	$71.44	0
2024-Q4	Increased	13M	+23.8%	$853.9M	0.2%	$65.45	46
2024-Q3	Increased	10.5M	+8.3%	$737.7M	0.2%	$70.58	41
2024-Q2	Increased	9.7M	+48.6%	$798M	0.2%	$82.33	52
2024-Q1	Decreased	6.5M	-39.5%	$569.5M	0.1%	$87.34	0
2023-Q4	Increased	10.8M	+79.0%	$1B	0.3%	$96.42	58
2023-Q3	Decreased	6M	-10.9%	$532.5M	0.1%	$88.48	0
2023-Q2	Decreased	6.8M	-6.3%	$585.7M	0.2%	$88.93	0
2023-Q1	Increased	7.2M	+27.6%	$701M	0.2%	$95.29	47
2022-Q4	Increased	5.7M	+14.5%	$584.8M	0.2%	$103.49	43
2022-Q3	Increased	4.9M	+0.0%	$418.5M	0.1%	$85.06	37
2022-Q2	Decreased	4.9M	-47.4%	$409M	0.1%	$83.92	0
2022-Q1	Decreased	9.4M	-25.9%	$723.8M	0.2%	$77.89	0
2021-Q4	Decreased	12.7M	-28.2%	$1.1B	0.2%	$89.08	0
2021-Q3	Decreased	17.6M	-20.1%	$1.4B	0.3%	$76.79	0
2021-Q2	Increased	22.1M	+0.1%	$1.8B	0.4%	$83.46	38
2021-Q1	Decreased	22.1M	-0.0%	$1.7B	0.4%	$74.96	0
2020-Q4	Increased	22.1M	+0.1%	$1.9B	0.5%	$86.96	45
2020-Q3	Decreased	22.1M	-0.0%	$1.7B	0.5%	$76.00	0
2020-Q2	Increased	22.1M	+0.1%	$2.7B	0.9%	$122.18	45
2020-Q1	Increased	22M	+0.2%	$1.9B	0.7%	$82.49	45
2019-Q4	Increased	22M	+1.4%	$1.9B	0.6%	$84.59	45
2019-Q3	Increased	21.7M	+10.2%	$1.5B	0.5%	$68.31	42
2019-Q2	Increased	19.7M	+11.0%	$1.7B	0.5%	$85.65	50
2019-Q1	Decreased	17.7M	-3.0%	$1.6B	0.5%	$88.83	0
2018-Q4	New	18.3M	-	$1.6B	0.5%	$83.60	62

Other major holders of BMRN: BNP PARIBAS FINANCIAL MARKETS, PRIMECAP MANAGEMENT CO/CA/, BlackRock Finance, Inc.

BMRN31 quarters

BMRN
31 quarters